Zydus receives USFDA tentative approval for Pregabalin Capsules

Zydus Cadila has received a tentative approval from USFDA for Pregabalin Capsules (US RLD Lyrica) in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad. Pregabalin is used to help control certain kinds of seizures, painful nerve diseases and fibromyalgia.

Powered by Capital Market - Live News